0:00
30:42
In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.
Weitere Episoden von „Goldman Sachs Talks“
Verpasse keine Episode von “Goldman Sachs Talks” und abonniere ihn in der kostenlosen GetPodcast App.